- Home
- GGN vs TLRY Comparison
GGN vs TLRY Comparison
Compare GGN & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GGN | TLRY |
|---|---|---|
| Founded | 2005 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 877.0M | 688.9M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | GGN | TLRY |
|---|---|---|
| Price | $5.14 | $5.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $72.33 |
| AVG Volume (30 Days) | 470.7K | ★ 3.5M |
| Earning Date | 01-01-0001 | 04-01-2026 |
| Dividend Yield | ★ 10.26% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.79 |
| Revenue Next Year | N/A | $19.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.31 | $0.36 |
| 52 Week High | $5.88 | $15.70 |
Technical Indicators
Market Signals| Indicator | GGN | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 37.64 | 42.97 |
| Support Level | $5.09 | $5.09 |
| Resistance Level | $5.32 | $7.01 |
| Average True Range (ATR) | 0.07 | 0.21 |
| MACD | -0.01 | 0.06 |
| Stochastic Oscillator | 21.25 | 68.95 |
Price Performance
Historical ComparisonAbout GGN GAMCO Global Gold Natural Resources & Income Trust
GAMCO Global Gold Natural Resources & Income Trust is a non-diversified closed-end management investment company. Its primary investment objective is to provide a high current income and capital appreciation as its secondary objective. To achieve its objective, the fund may invest majority of its assets in equity securities of companies principally engaged in the gold and natural resources industries. It also intends to earn income through an option planning of writing (selling) covered call options on equity securities in its portfolio.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.